Clinico-pathological significance of suspicious peritoneal cytology in endometrial cancer

被引:5
作者
Matsuo, Koji [1 ,2 ]
Matsuzaki, Shinya [1 ]
Miller, Heather [1 ]
Nusbaum, David J. [3 ]
Walia, Saloni [4 ]
Matsuzaki, Satoko [1 ]
Shimada, Muneaki [5 ]
Klar, Maximilian [6 ]
Roman, Lynda D. [1 ,2 ]
机构
[1] Univ Southern Calif, Div Gynecol Oncol, Dept Obstet & Gynecol, 2020 Zonal Ave,IRD 520, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA
[3] Univ Chicago, Sch Med, Dept Urol, Chicago, IL 60637 USA
[4] Univ Southern Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90007 USA
[5] Tohoku Univ, Dept Obstet & Gynecol, Sch Med, Sendai, Miyagi, Japan
[6] Univ Freiburg, Dept Obstet & Gynecol, Freiburg, Germany
关键词
characteristic; endometrial cancer; peritoneal cytology; survival; suspicious; CARCINOMA; DISSEMINATION; HYSTEROSCOPY; SURVIVAL; RISK; HYSTERECTOMY; PREDICTION; GUIDELINES; CELLS;
D O I
10.1002/jso.26570
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives Suspicious peritoneal cytology refers to the result of peritoneal cytology testing that is insufficient in either quality or quantity for a definitive diagnosis of malignancy. This study examined characteristics and survival outcomes related to suspicious peritoneal cytology in endometrial cancer. Methods A population-based retrospective study by querying the National Cancer Institute's Surveillance, Epidemiology, and End Results Program was conducted. A total of 41,229 women with Stage I-III endometrial cancer who had peritoneal cytologic sampling at hysterectomy from 2010 to 2016 were examined. A Cox proportional hazard regression model and a competing risk analysis with Fine-Gray model were fitted to assess survival outcome related to suspicious peritoneal cytology. Results Suspicious peritoneal cytology was seen in 702 (1.7%) cases. In multivariable models, suspicious peritoneal cytology was associated with increased risk of endometrial cancer mortality (subdistribution-hazard ratio [HR] 1.69, 95% confidence interval [CI] 1.29-2.20, p < 0.001) and all-cause mortality (adjusted-HR: 1.55, 95% CI: 1.27-1.90, p < 0.001) compared with negative peritoneal cytology. Sensitivity analysis demonstrated that suspicious peritoneal cytology had discrete overall survival improvement compared with malignant peritoneal cytology in a propensity score weighting model (HR: 0.85, 95% CI: 0.72-0.99, p = 0.049). Conclusion Our study suggests that suspicious peritoneal cytology may be a prognostic factor for decreased survival in endometrial cancer.
引用
收藏
页码:687 / 698
页数:12
相关论文
共 40 条
[1]  
[Anonymous], INT CLASSIFICATION D
[2]  
[Anonymous], CANC I SURV EP END R
[3]  
[Anonymous], CANC REG ASS
[4]   Introduction to the Analysis of Survival Data in the Presence of Competing Risks [J].
Austin, Peter C. ;
Lee, Douglas S. ;
Fine, Jason P. .
CIRCULATION, 2016, 133 (06) :601-609
[5]   Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies [J].
Austin, Peter C. ;
Stuart, Elizabeth A. .
STATISTICS IN MEDICINE, 2015, 34 (28) :3661-3679
[6]   Stage IIIA Endometrial Carcinoma Outcome and Predictors of Survival [J].
Bansal, Sharmilee ;
Buck, Adam M. ;
Herzog, Thomas J. ;
Deutsch, Israel ;
Burke, William M. ;
Wright, Jason D. .
OBSTETRICS AND GYNECOLOGY, 2009, 114 (01) :100-105
[7]   Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis [J].
Chang, Ya-Nan ;
Zhang, Ying ;
Wang, Yong-Jun ;
Wang, Li-Ping ;
Duan, Hua .
FERTILITY AND STERILITY, 2011, 96 (04) :957-U414
[8]  
Corpus, CARC CS SIT SPEC FAC
[9]   A proportional hazards model for the subdistribution of a competing risk [J].
Fine, JP ;
Gray, RJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) :496-509
[10]   Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer [J].
Garg, Gunjal ;
Gao, Feng ;
Wright, Jason D. ;
Hagemann, Andrea R. ;
Mutch, David G. ;
Powell, Matthew A. .
GYNECOLOGIC ONCOLOGY, 2013, 128 (01) :77-82